Information about Prilenia Therapeutics
My details
*
*
*

Prilenia Therapeutics (BV)

Company information

Status
Active

KVK number

76494187

VAT Number

NL 860644480 B01
Established
25-11-2019
Last balance sheet year
2025
Company size
Big 0 FTE
Legal form
Besloten Vennootschap (BV)
RSIN number
860644480
Principal activity
Research and experimental development on natural sciences and engineering
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Prilenia Therapeutics

2025 2024 2022 2021
Balance sheet
Balance sheet total € 150.432.839 -1% € 152.483.171 32% € 115.091.338 19% € 96.712.478
Equity € 104.694.898 -11% € 117.793.203 3% € 114.117.768 19% € 95.851.448
Debts € 45.737.941 32% € 34.689.968 - € 861.030
Other
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Prilenia Therapeutics?
The KVK number of Prilenia Therapeutics is 76494187
What is the VAT number of Prilenia Therapeutics?
The VAT number of Prilenia Therapeutics is NL 860644480 B01.
Wat is the PEPPOL ID of Prilenia Therapeutics?
There is no information available about the PEPPOL ID of Prilenia Therapeutics or the company is not yet registered on the PEPPOL network.
When was Prilenia Therapeutics founded?
Prilenia Therapeutics was founded on 25-11-2019.
What is the address of Prilenia Therapeutics?
The current registered office of Prilenia Therapeutics is located at Gooimeer 2/35, 1411 DC Naarden.
When was the last time Prilenia Therapeutics filed their annual financial statements?
The most recent financial statements of Prilenia Therapeutics were filed on 31-12-2025.
How many employees does Prilenia Therapeutics have?
There are currently no employees working at Prilenia Therapeutics or no workforce information is available.
What is the annual turnover of Prilenia Therapeutics?
There is no turnover available for Prilenia Therapeutics.